Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil, 0.01%

Deepthi | Myequity news | Date : 18-12-2018 10:05:00 IST

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fluocinolone Acetonide Oil, 0.01% (Ear Drops), a generic version of DermOtic®1 Oil, 0.01% (Ear Drops), of Hill Dermaceuticals, Inc.

According to IQVIATM sales data for the 12 month period ending October 2018, the DermaOtic® Oil, 0.01% (Ear Drops) market2 achieved annual sales of approximately $18.1 million.

About Glenmark Pharmaceuticals:

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical organization. Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is focused in the areas of oncology, dermatology and respiratory.



More from Myequity